Arterial tissue and plasma concentration of enzymatic-driven oxysterols are associated with severe peripheral atherosclerotic disease and systemic inflammatory activity

Free Radical Research

Volumn 49, Issue 2, 2015, Pages 199-203

  Virginio, V W M ^a   Nunes, V S ^b   Moura, F A ^a   Menezes, F H ^a   Andreollo, N A ^a   Rogerio, F ^a   Scherrer, D Z ^a   Quintao E C R ^b   Nakandakare, E ^b   Petrucci, O ^a   Nadruz, W ^a   De Faria, E C ^a   Sposito, A C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

24S hydroxycholesterol; Atherosclerosis; Oxysterols; Peripheral artery disease

Indexed keywords

24 HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; C REACTIVE PROTEIN; OXYSTEROL; UNCLASSIFIED DRUG; 24-HYDROXYCHOLESTEROL; 25-HYDROXYCHOLESTEROL; 27-HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE;

ADULT; AGED; ARTERY INTIMA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SYSTOLIC BLOOD PRESSURE; ARTERY; BLOOD; CHEMISTRY; INFLAMMATION; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTERIES; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; INFLAMMATION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

EID: 84926640379     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.992894     Document Type: Article

References (20)

1. Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK, Mitchinson MJ. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res 2001; 35: 31-41.
2. Vaya J, Aviram M, Mahmood S, Hayek T, Grenadir E, Hoffman A, Milo S. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 2001; 34: 485-497.
3. van Reyk DM, Brown AJ, Hult'en LM, Dean RT, Jessup W. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep 2006; 11: 255-262.
4. Khatib S, Vaya J. Oxysterols and symptomatic versus asymptomatic human atherosclerotic plaque. Biochem Biophys Res Commun 2014; 446: 709-713.
5. Hodis HN, Crawford DW, Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 1991; 89: 117-126.
6. Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995; 225: 73-80.
7. Babiker A, Diczfalusy U. Transport of side-chain oxidized oxysterols in the human circulation. Biochim Biophys Acta 1998; 1392: 333-339.
8. Bjorkhem I, Andersson U, Ellis E, Alvelius G, Ellegard L, Diczfalusy U, et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem 2001; 276: 37004-37010.
9. Fujiyoshi M, Ohtsuki S, Hori S, Tachikawa M, Terasaki T. 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoformdependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. J Neurochem 2007; 100: 968-978.
10. Leoni V, Caccia C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie 2013; 95: 595-612.
11. Hulten LM, Lindmark H, Diczfalusy U, Bjorkhem I, Ottosson M, Liu Y, et al. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest 1996; 97: 461-468.
12. Schroepfer GJ Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000; 80: 361-554.
13. Reiss AB, Martin KO, Rojer DE, Iyer S, Grossi EA, Galloway AC, Javitt NB. Sterol 27-hydroxylase: expression in human arterial endothelium. J Lipid Res 1997; 38: 1254-1260.
14. Babiker A, Andersson O, Lund E, Xiu RJ, Deeb S, Reshef A, et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997; 272: 26253-26261.
15. Upston JM, Niu X, Brown AJ, Mashima R, Wang H, Senthilmohan R, et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 2002; 160: 701-710.
16. Poli G, Biasi F, Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. Redox Biol 2013; 1: 125-130.
17. Lathe R, Sapronova A, Kotelevtsev Y. Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatr 2014; 14: 36.
18. Kudo K, Emmons GT, Casserly EW, Via DP, Smith LC, St Pyrek J, Schroepfer GJ Jr. Inhibitors of sterol synthesis. Chromatography of acetate derivatives of oxygenated sterols. J Lipid Res 1989; 30: 1097-1111.
19. Brown AJ, Jessup W. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol Aspects Med 2009; 30: 111-122.
20. Jusakul A, Yongvanit P, Loilome W, Namwat N, Kuver R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis 2011; 10: 44.